MCA ListingListing Guidance, Version 2, 9 January 2026
Superseded. This text is retained for historical reference. Replacement: MCA-GL-117 — Version 1, 19 June 2026 →
Listing Guidance, Version 2, 9 January 2026 is the official MCA identifier for “Guidance to Manufacturers, Marketing Authorization Holders and Importers for Listing of Medicines and Related Products”. Listing Guidance, Version 2, 9 January 2026 is the official identifier MCA uses for this instrument.
- Instrument
- Listing
- Full name
- Listing Guidance, Version 2, 9 January 2026
- Category
- Registration
- Source publication
- English
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Guidance to Manufacturers, Marketing Authorization Holders and Importers for Listing of Medicines and Related Products
Complete four-page MCA listing guidance, Version 2 dated 9 January 2026. It describes the listing mechanism introduced by the Medicines and Related Products (Amendment) Act 2023 and expressly identifies a separate listing application for medical devices. The original text is retained without turning its references to other product categories into device-specific requirements. The formal MCA-GL-117 guideline effective 19 June 2026 expressly replaces this guidance.
Listing Guidance, Version 2, 9 January 2026 is the official identifier MCA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.